Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAT NANO, officially known as Xiamen SAT Nano Technology Co., Ltd., is a high-tech enterprise specializing in the research, development, and production of nanomaterials and nanopowders. The company provides a wide range of products including metal nanoparticles, oxide nanopowders, and carbon-based nanomaterials used across various industries such as electronics, energy, and healthcare. In the life sciences sector, their materials are utilized for antibacterial applications, medical imaging contrast agents, and advanced drug delivery systems. SAT NANO focuses on providing high-purity materials to research institutions and industrial partners globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAT NANO.